Global Respiratory Pathogen Kits Market Size, Trends & Growth Opportunity, By Test Type (Pulmonary Function Tests, OSA Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, and Others), By Diseases (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Diseases, and Others), By End User (Hospital Clinical Laboratories, Reference laboratories, Physician Offices, and Others), By Region and Forecast till 2027.
Report ID : IR1001914 | Industries : Energy & Power | Published On :June 2024 | Page Count : 234
Global Respiratory Pathogen Kits Market Size, Trends & Growth Opportunity, By Test Type (Pulmonary Function Tests, OSA Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, and Others), By Diseases (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Diseases, and Others), By End User (Hospital Clinical Laboratories, Reference laboratories, Physician Offices, and Others), By Region and Forecast till 2027.
Global Respiratory Pathogen Kits Market
The Global Respiratory Pathogen Kits Market is expected to grow from US$ 2.49 Billion in 2021 to US$ 5.67 Billion by 2027; it is estimated to grow at a CAGR of 14.7% from 2022 to 2027.
Market Overview
A respiratory pathogen testing kit is used to diagnose respiratory illnesses by analysing blood, fluids, or tissue from the afflicted area of the body. Respiratory pathogen testing tools are able to identify the genetic material (RNA/DNA) of some of the most common infections. It can recognise multiple bacterial pathogens and locate bacteria that conventional tests, like cultures, might overlook. Several testing tools can identify specific microorganism subgroups or strains.
Market Drivers
The main factor anticipated to fuel the growth of the global market for respiratory pathogen kits is the rise in the prevalence of respiratory diseases. Additionally, the market will benefit from shifting lifestyles, urbanization, rising pollution levels, and the high prevalence of tobacco use. Additionally, during this forecast time, increased technological advancements will drive market expansion.
Market Restraints
The main factor anticipated to restrain the growth of the global respiratory pathogen kits market is the rise in healthcare costs, which are restricting the use of novel respiratory diagnostics techniques. Concerns about payment will also hinder market expansion.
Impact of Covid-19
The COVID-19 pandemic had a positive impact on the respiratory pathogen testing kits industry, as well as other diagnostics and biotechnology sectors. COVID-19 has contributed to an increase in the demand for pathogen testing technology to identify molecular tests and map COVID-19 antibodies for Covid-19 infection. The higher demand for COVID-19 vaccines has boosted research and development efforts during Covid-19. It is owing to the daily increase in COVID-19 cases worldwide. Several businesses used product launches to try immune monitoring, diagnostic tests, and vaccine development.
Market Segmentation
Global Respiratory Pathogen Kits Market is segmented into test type such as Pulmonary Function Tests, OSA Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, and others, by diseases such as Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Diseases, and Others. Further market is segmented into end user such as Hospital Clinical Laboratories, Reference laboratories, Physician Offices, and Others.
Also, Global Respiratory Pathogen Kits Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Key Developments
• November 2021 Philips expands its ultrasound product line with new, powerful imaging tools and features for radiology to boost productivity effectiveness and diagnostic assurance.
• ABBOTT revealed the release of Similac 360 Total Care in November 2021, the brand's next-generation infant formula with HMOs, significant prebiotics with a structural similarity to those found in human breast milk.
Market Key Players
Various key players are discussed in this report such as Philips Healthcare, Becton, Dickinson & Company, Abbott Laboratories, Thermo Fisher Scientific Inc., Biomérieux, Alere Inc, Bio-Rad Laboratories, Inc., Cosmed, and Seegene Inc.
Market Taxonomy
By Test Type
• Pulmonary Function Tests
• OSA Diagnostic Tests
• Imaging Tests
• Traditional Diagnostic Tests
• Molecular Diagnostic Tests
• Others
By Diseases
• Tuberculosis
• Asthma
• Lung Cancer
• Chronic Obstructive Pulmonary Diseases
• Others
By End User
• Hospital Clinical Laboratories
• Reference laboratories
• Physician Offices
• Others
By Region
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa
Key Questions Addressed by the Report
• What are the Key Opportunities in Global Respiratory Pathogen Kits Market?
• What will be the growth rate from 2022 to 2027?
• Which segment/region will have highest growth?
• What are the factors that will impact/drive the Market?
• What is the competitive Landscape in the Industry?
• What is the role of key players in the value chain?
• What are the strategies adopted by key players?
Global Respiratory Pathogen Kits Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Respiratory Pathogen Kits Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing Economic Downturn
4.2.6 Post Covid-19 World Supply & Demand Conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Respiratory Pathogen Kits Market, By Test Type
5.1 Y-o-Y Growth Comparison, By Test Type
5.2 Global Respiratory Pathogen Kits Market Share Analysis, By Test Type
5.3 Global Respiratory Pathogen Kits Market Size and Forecast, By Test Type
5.3.1Pulmonary Function Tests
5.3.2 OSA Diagnostic Tests
5.3.3Imaging Tests
5.3.4Traditions Diagnostic Test
5.3.5Molecular Diagnostic Test
5.3.6Others
6 Global Respiratory Pathogen Kits Market , By Diseases
6.1 Y-o-Y Growth Comparison, By Diseases
6.2 Global Respiratory Pathogen Kits Market Share Analysis, By Diseases
6.3 Global Respiratory Pathogen Kits Market Size and Forecast, By Diseases
6.3.1 Tuberculosis
6.3.2 Asthma
6.3.3Lung Cancer
6.3.4Chronic Obstructive Pulmonary Diseases
6.3.5Others
7 Global Respiratory Pathogen Kits Market, By End User
7.1 Y-o-Y Growth Comparison, By End User
7.2 Global Respiratory Pathogen Kits Market Share Analysis, By End User
7.3 Global Respiratory Pathogen Kits Market Size and Forecast, By End User
7.3. 1 Hospital Clinical Laboratories
7.3.2Reference Laboratories
7.3.3Physician Offices
7.3.4Others
8Global Respiratory Pathogen Kits Market, By Region
8.1 Global Respiratory Pathogen Kits Market Share Analysis, By Region
8.2 Global Respiratory Pathogen Kits Market Share Analysis, By Region
8.3 Global Respiratory Pathogen Kits Market Size and Forecast, By Region
9 North America Respiratory Pathogen Kits Market Analysis and Forecast (2022 – 2027)
9.1 Introduction
9.2 North America Respiratory Pathogen Kits Market Share Analysis, By Test Type
9.3 North America Respiratory Pathogen Kits Market Size and Forecast, By Diseases
9.4 North America Respiratory Pathogen Kits Market Size and Forecast, By End User
9.5 North America Respiratory Pathogen Kits Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10EuropeRespiratory Pathogen Kits Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 Europe Respiratory Pathogen Kits Market Share Analysis, By Test Type
10.3 Europe Respiratory Pathogen Kits Market Size and Forecast, By Diseases
10.4 Europe Respiratory Pathogen Kits Market Size and Forecast, By End User
10.5 Europe Respiratory Pathogen Kits Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11Asia Pacific Respiratory Pathogen Kits Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Asia Pacific Respiratory Pathogen Kits Market Share Analysis, By Test Type
11.3 Asia Pacific Respiratory Pathogen Kits Market Size and Forecast, By Diseases
11.4 Asia Pacific Respiratory Pathogen Kits Market Size and Forecast, By End User
11.5 Asia Pacific Respiratory Pathogen Kits Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12Latin America Respiratory Pathogen Kits Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Latin America Respiratory Pathogen Kits Market Share Analysis, By Test Type
12.3 Latin America Respiratory Pathogen Kits Market Size and Forecast, By Diseases
12.4 Latin America Respiratory Pathogen Kits Market Size and Forecast, By End User
12.5 Latin America Respiratory Pathogen Kits Market Size and Forecast, Country
13Middle East Respiratory Pathogen Kits Market Analysis and Forecast (2022 – 2027)
13.1 Introduction
13.2 Middle East Respiratory Pathogen Kits Market Share Analysis, By Test Type
13.3 Middle East Respiratory Pathogen Kits Market Size and Forecast, By Diseases
13.4 Middle East Respiratory Pathogen Kits Market Size and Forecast, By End User
13.5 Middle East Respiratory Pathogen Kits Market Size and Forecast, By Country
14Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15Company Profiles
15.1 Philips Healthcare
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2 Becton, Dickinson & Company
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3 Abbott Laboratories
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Thermo Fisher Scientific Inc
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Biomérieux
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Alere Inc
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Bio-Rad Laboratories, Inc
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Cosmed
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Seegene Inc
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies